Xalkori (crizotinib)

pCPA File Number: 20747
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-Squamous Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
PC0017-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: